Why LGBTQ+ people die from drugs and alcohol at far higher rates in the UK and what we need to do

What is it about?

This commentary draws on new 2026 ONS data showing that lesbian, gay, bisexual and other sexual minoritised people in England and Wales face a 1.8-fold greater risk of alcohol-specific death and a 2.8-fold greater risk of drug poisoning death than heterosexual people. Data for transgender and gender diverse people, though largely absent from official records, point to even starker disparities. The paper examines why these gaps exist, covering minority stress, the role of LGBTQ+ venues and chemsex environments, heteronormative treatment services, and a fundamental failure to collect or publish data disaggregated by sexual orientation and gender identity. It closes with a practical set of policy and clinical recommendations across data systems, workforce training, harm reduction, and upstream determinants of health.

Featured Image

Why is it important?

The UK is in the middle of a record drug and alcohol death crisis, yet national drug strategy and treatment infrastructure effectively treat LGBTQ+ people as invisible. This commentary is the first to respond directly to the landmark 2026 ONS mortality statistics, framing them as both an indictment of decades of policy neglect and a call to action. By naming the specific mechanisms driving excess mortality, including minority stress, barriers to gender-affirming care, alcogenic community spaces, and data erasure in national surveillance systems, it provides a concrete framework for commissioners, clinicians and policymakers. The recommendations address structural and clinical gaps simultaneously, making this a key reference for anyone working on health equity, substance use treatment commissioning, LGBTQ+ health, or drug policy reform in the UK.

Perspectives